2012 — Founded & Early R&D

TingProbiotics was founded in 2012, beginning with a focus on R&D in probiotic and microecological formulations. In the same year, we established industry-academia partnerships with Jiangsu University and Yangzhou University. The founder, Jiang Xiaoting, led the research team in the company‘s early stage.

2015 — Product Launch & Patent

After years of R&D and market research, our first probiotic products were launched in 2015. We were granted a national patent, and the company was recognized by the Nanjing 321 Program for Leading Technology Entrepreneurs — a government-backed initiative supporting high-tech innovation in Nanjing.

2016 — National Distribution

We expanded through traditional sales channels, building a nationwide network of franchise stores. Our brand was recognized as a “Selected Brand” on CCTV.com Mall, reflecting growing consumer trust in the China market.

2017 — Innovation Model

We introduced a new business model combining traditional distribution with sharing-economy principles. That year, we were recognized as one of the Top 10 Most Influential Enterprises in China’s Biotechnology Sector.

2016–2020 — Channel Expansion

Through investment promotion by Nanjing Yuhuatai District, we established a presence in the Software Valley Science and Technology City. By combining physical retail with e-commerce platforms, we brought our probiotic products to a wider consumer base across China.

2021 — Zaozhuang Investment & Joint Lab

We relocated part of our operations to Zaozhuang High-tech Zone through a local government investment promotion program. We established a joint laboratory for functional composite microecological formulations with Jiangnan University, and founded the Qianfang Precision Research Institute, bringing together PhDs and academicians from China and abroad.

2023 — Provincial Key Project & Manufacturing Base

Our probiotic production base in Zaozhuang was recognized as a Provincial Key Construction Project and a Provincial Priority Project for Investment & Talent Introduction. The project covers approximately 70,000 square meters with a total investment of RMB 1 billion. It includes fully automated production lines for probiotic solid beverages, stick sachets, and dietary fiber powders. We also added more than 30 new formulations and products.

2024 — International Cooperation & Market Validation

In December 2024, Boli Capital entered into a memorandum of understanding with Tingchuang (Tancheng) Biotechnology for strategic cooperation, including business collaboration, product promotion, and potential investment. Our international R&D team includes foreign experts such as Dr. Raza, who leads our strain research work. In the same month, our Tancheng production base held its official opening ceremony. Earlier in the year, our pomegranate probiotic product received orders for 110,000 boxes within the first weeks of launch. This product was developed using locally sourced pomegranate resources in Zaozhuang, combining antioxidant-focused strains with pomegranate extract.

2025 — Building a Circular Probiotic Ecosystem

We are now working to build a circular probiotic industry ecosystem — integrating R&D, manufacturing, and market services to support long-term sustainable growth. Our goal is to be a reliable OEM/ODM partner for brands worldwide, backed by science, quality, and scalable production.